Joint Funding Call 2023: Repurposing therapies for EB
We are delighted to announce that DEBRA Austria and LifeArc, are partnering to commit £2.5 million to fund projects to repurpose therapeutics that can be brought rapidly to patients suffering from Epidermolysis Bullosa (EB). Expressions-of-interest (EOI) are now being invited from research groups based at academic institutions or hospitals worldwide. There will be a priority […]
Joint Funding Call 2023: Repurposing therapies for EB Leggi tutto »